COVID-19 or Flu?

Get the answers with Flowflex PLUS

The Flowflex® PLUS COVID-19 and Flu A/B Home Test is all you need to determine your family’s COVID-19/Flu status.

Symptoms may be similar, treatments for complications differ

  • 3-in-1 test for COVID-19, Flu A, and Flu B
  • Easy-to-use nasal swab test
  • Can be used to test children as young as 2 years old
  • Results in 15 minutes
  • No need to send off to a lab to obtain results
  • Medical-grade technology used in doctor’s offices
  • Compact packaging for “On-The-Go” testing
The Flowflex™ COVID-19 Antigen Home Test
Expiration Date Extension

As of January 14, 2025, the expiration date of the Flowflex Plus COVID-19 and Flu A/B Home Test has been extended by 3 months. Please click here to check the new expiration date using the lot number printed on the test kit box

Test Procedure Overview

This test procedure overview does not replace the Quick Reference Instructions (QRI). Before you begin the test, it is important to read and follow the detailed instructions in the QRI.

Resources

Quick Reference Instructions (English)

Quick Reference Instructions (Spanish)

Fact Sheet for Healthcare Professionals

Healthcare Provider Package Insert

Quick Instruction Card (English)

Quick Instruction Card (Spanish)

Frequently Asked Questions

Become an Authorized Distributor, click here.
The Flowflex™ COVID-19 Antigen Home Test

Looking for a Distributor?

To locate an authorized US distributor, please click the button.

Need Support?

News

Headquartered in San Diego, California, ACON Laboratories makes point-of-care medical diagnostics accessible to people around the world. ACON provides rapid diagnostics and healthcare products based on a philosophy of high quality at affordable prices.

  • In the USA, this product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization.
  • This product has been authorized only for the detection of proteins from SARSCoV-2, influenza A and influenza B, not for any other viruses or pathogens.
  • The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

For more information on EUAs please visit: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

For the most up to date information on COVID-19, please visit: www.cdc.gov/COVID19

Skip to content